{"date":"2026-03-05","count":113,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3218-2026-03-05-2135-puz82e","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"21:35:15","subject":"本公司受邀參加花旗環球證券之2025Q4線上法說會議","clause":"第12款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-05 21:35，「本公司受邀參加花旗環球證券之2025Q4線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-2117-9m1vil","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"21:17:35","subject":"公告本公司於今日召開重大訊息說明記者會之相關內容。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 21:17，「公告本公司於今日召開重大訊息說明記者會之相關內容。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-2117-ozpe3","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"21:17:22","subject":"更正公告本公司董事會決議通過辦理減資彌補虧損案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 21:17，「更正公告本公司董事會決議通過辦理減資彌補虧損案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-03-05-2050-8zw102","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"20:50:25","subject":"本公司改派重要子公司董事會成員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-03-05 20:50，「本公司改派重要子公司董事會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-2042-1e7tonh","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"20:42:39","subject":"代重要子公司棉花田生機園地(股)公司公告董事會決議解除經理人競業禁止之限制事宜","clause":"第21款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 20:42，「代重要子公司棉花田生機園地(股)公司公告董事會決議解除經理人競業禁止之限制事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-2039-1u9tau7","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"20:39:31","subject":"代重要子公司棉花田生機園地(股)公司公告董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 20:39，「代重要子公司棉花田生機園地(股)公司公告董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-2037-1cvqx50","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"20:37:19","subject":"代重要子公司棉花田生機園地(股)公司公告董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 20:37，「代重要子公司棉花田生機園地(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-2034-111z6pt","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"20:34:39","subject":"代重要子公司棉花田生機園地(股)公司公告董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 20:34，「代重要子公司棉花田生機園地(股)公司公告董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1953-17sx5nz","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"19:53:16","subject":"代重要子公司棉花田生機園地(股)公司公告董事會決議向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 19:53，「代重要子公司棉花田生機園地(股)公司公告董事會決議向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1946-130zy9f","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"19:46:39","subject":"本公司董事會決議發行115年度限制員工權利新股案","clause":"第11款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 19:46，「本公司董事會決議發行115年度限制員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1941-1srwb8g","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"19:41:26","subject":"公告本公司董事會決議發行115年第一次員工認股權憑證","clause":"第11款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 19:41，「公告本公司董事會決議發行115年第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1939-2tothz","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:39:32","subject":"代子公司「蘇州中化藥品工業有限公司」公告總經理異動","clause":"第6款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:39，「代子公司「蘇州中化藥品工業有限公司」公告總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1926-bwopfv","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"19:26:30","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 19:26，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1922-1nb8hvk","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"19:22:19","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 19:22，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1916-1m9ar33","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:16:32","subject":"公告本公司董事會通過114年度第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:16，「公告本公司董事會通過114年度第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1907-qr6lvv","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:07:55","subject":"本公司董事會決議辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:07，「本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1907-92x690","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:07:36","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:07，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1902-5gf7ly","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:02:16","subject":"本公司董事會決議辦理私募發行國內可轉換公司債(包括有擔保或無擔保可轉換公司債）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:02，「本公司董事會決議辦理私募發行國內可轉換公司債(包括有擔保或無擔保可轉換公司債）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1901-3sk96k","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"19:01:59","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 19:01，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1858-za0iyu","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"18:58:43","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 18:58，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-05-1857-akhno1","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"18:57:58","subject":"本公司召開115年股東常會相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-05 18:57，「本公司召開115年股東常會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-03-05-1857-11wvmau","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:57:16","subject":"公告本公司董事會決議召開115年度股東常會事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-03-05 18:57，「公告本公司董事會決議召開115年度股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-03-05-1847-1dd9qx8","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:47:54","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-05 18:47，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-03-05-1811-ha84r7","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:11:08","subject":"代子公司New Path International Co., Ltd.依公開發行公司資金貸與及背書保證處理準則第25條第一項第一款規定公告背書保證予本公司","clause":"第22款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-03-05 18:11，「代子公司New Path International Co., Ltd.依公開發行公司資金貸與及背書保證處理準則第25條」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-03-05-1810-92x690","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:10:38","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-03-05 18:10，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-03-05-1808-1y7y85y","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"18:08:44","subject":"代重要子公司新高製藥(股)公司公告董事會決議不發放股利","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-03-05 18:08，「代重要子公司新高製藥(股)公司公告董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-03-05-1808-fm6udg","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:08:32","subject":"公告本公司董事會決議通過召開股東會之相關事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-03-05 18:08，「公告本公司董事會決議通過召開股東會之相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-03-05-1807-1lwyafl","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:07:53","subject":"本公司114年第4季合併財務報告經提報董事會通過","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-03-05 18:07，「本公司114年第4季合併財務報告經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-03-05-1807-1nq1fjk","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"18:07:52","subject":"本公司董事會決議除息基準日","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-05 18:07，「本公司董事會決議除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1756-hp9t8","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:45","subject":"公告本公司董事會決議通過辦理減資彌補虧損案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:56，「公告本公司董事會決議通過辦理減資彌補虧損案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-03-05-1756-fx98nb","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:39","subject":"代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-03-05 17:56，「代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1756-oi9rmi","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:32","subject":"本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:56，「本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-03-05-1756-11b1948","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:23","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-03-05 17:56，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1756-11wyb5x","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:19","subject":"公告本公司稽核主管任用案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:56，「公告本公司稽核主管任用案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-03-05-1756-5j9yh6","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:11","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-03-05 17:56，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1756-1jp3ewj","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:56:04","subject":"公告本公司董事會通過114年度財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:56，「公告本公司董事會通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-03-05-1755-g4f4aa","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:55:58","subject":"公告本公司董事會通過114年度個體財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-03-05 17:55，「公告本公司董事會通過114年度個體財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1755-92x690","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:55:51","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:55，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-03-05-1755-1howjn","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:55:38","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-03-05 17:55，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1755-13tl3ny","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"17:55:23","subject":"本公司董事會決議虧損撥補及不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 17:55，「本公司董事會決議虧損撥補及不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-05-1753-nt5gla","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:53:24","subject":"公告董事會決議股利分派","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-05 17:53，「公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-03-05-1750-1dfq8td","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:50:41","subject":"公告本公司董事會決議配發股利","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-05 17:50，「公告本公司董事會決議配發股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-03-05-1749-tlfv07","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"17:49:02","subject":"公告本公司115年召開股東常會相關事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-03-05 17:49，「公告本公司115年召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1746-5heha4","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"17:46:40","subject":"公告本公司董事會決議召開115年股東常會及國內轉換公司債停止轉換期間","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 17:46，「公告本公司董事會決議召開115年股東常會及國內轉換公司債停止轉換期間」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1742-1wou118","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:42:34","subject":"公告本公司董事會通過對子公司漢瑞投資股份有限公司現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 17:42，「公告本公司董事會通過對子公司漢瑞投資股份有限公司現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-03-05-1737-1q2r2w9","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:37:34","subject":"公告本公司董事會決議不分派114年度股利","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-03-05 17:37，「公告本公司董事會決議不分派114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-05-1734-11b1948","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:34:47","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-05 17:34，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-05-1734-1jixu6b","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:34:01","subject":"公告本公司董事會決議召開115年第一次股東臨時會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-05 17:34，「公告本公司董事會決議召開115年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-05-1733-5j9yh6","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:33:15","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-05 17:33，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-05-1732-84656m","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:32:03","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-05 17:32，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-03-05-1730-z0noun","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:30:12","subject":"公告本公司114年度累積虧損達實收資本二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-03-05 17:30，「公告本公司114年度累積虧損達實收資本二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-03-05-1730-11b1948","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:30:06","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-03-05 17:30，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-03-05-1728-bs2iu9","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"17:28:46","subject":"公告本公司董事會決議發放股利事宜。","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-03-05 17:28，「公告本公司董事會決議發放股利事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-03-05-1728-5j9yh6","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:28:29","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-05 17:28，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-03-05-1725-1b89la1","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:25:54","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-03-05 17:25，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-03-05-1724-4bdtmx","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:24:24","subject":"公告本公司更換股務代理機構","clause":"第44款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-03-05 17:24，「公告本公司更換股務代理機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-03-05-1724-1fgx4fh","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:24:00","subject":"公告本公司董事會決議通過114年度財務報表","clause":"第43款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-03-05 17:24，「公告本公司董事會決議通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-05-1723-1h039nn","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:23:56","subject":"公告本公司董事長依董事會授權決定限制員工權利新股之增資基準日","clause":"第53款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-05 17:23，「公告本公司董事長依董事會授權決定限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-05-1723-18ms4wh","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:23:24","subject":"公告本公司董事長決議股利配發基準日及發放日等相關事宜","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-05 17:23，「公告本公司董事長決議股利配發基準日及發放日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-03-05-1721-w2cwq9","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"17:21:20","subject":"公告本公司114年財務合併報告提報董事會。","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-03-05 17:21，「公告本公司114年財務合併報告提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-05-1720-1o5sa57","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:20:59","subject":"公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案","clause":"第11款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-05 17:20，「公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-05-1720-92x690","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:20:31","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-05 17:20，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-05-1720-5j9yh6","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:20:12","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-05 17:20，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-03-05-1719-1fqkmsr","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:19:02","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-03-05 17:19，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1718-snnsqw","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:18:32","subject":"公告本公司董事會決議分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 17:18，「公告本公司董事會決議分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-05-1716-7b3121","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:16:22","subject":"公告本公司董事會決議召開一一五年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-05 17:16，「公告本公司董事會決議召開一一五年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1706-1howjn","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:06:26","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 17:06，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-05-1702-130zy9f","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:02:33","subject":"本公司董事會決議發行115年度限制員工權利新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-05 17:02，「本公司董事會決議發行115年度限制員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-05-1702-1mvy42n","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"17:02:09","subject":"公告本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-05 17:02，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-05-1701-1ihcu87","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:01:20","subject":"代重要子公司創益生技股份有限公司公告董事會決議股利分派事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-05 17:01，「代重要子公司創益生技股份有限公司公告董事會決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-05-1700-1byvk4e","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"17:00:20","subject":"代重要子公司創益生技股份有限公司公告董事會決議通過115年股東常會之召集事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-05 17:00，「代重要子公司創益生技股份有限公司公告董事會決議通過115年股東常會之召集事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-03-05-1659-1howjn","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"16:59:30","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-03-05 16:59，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-05-1657-1onxk6d","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:57:54","subject":"本公司董事會決議發行一一五年第一次員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-05 16:57，「本公司董事會決議發行一一五年第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-05-1657-1howjn","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"16:57:52","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-05 16:57，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-05-1654-wircx2","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:54:23","subject":"公告本公司董事會決議通過115年股東常會之召集事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-05 16:54，「公告本公司董事會決議通過115年股東常會之召集事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-05-1653-1b89la1","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"16:53:43","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-05 16:53，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-05-1652-bwopfv","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:52:19","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-05 16:52，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-05-1652-5rax5d","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"16:52:09","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-05 16:52，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1649-17ot8lf","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:49:20","subject":"代子公司漢瑞投資股份有限公司公告辦理現金增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 16:49，「代子公司漢瑞投資股份有限公司公告辦理現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1646-b31x","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:46:48","subject":"公告本公司董事會通過盈餘轉增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 16:46，「公告本公司董事會通過盈餘轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1643-s57fxa","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:43:47","subject":"公告本公司114年度合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 16:43，「公告本公司114年度合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-05-1640-92x690","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:40:38","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-05 16:40，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-03-05-1638-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:38:42","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-03-05 16:38，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-05-1634-5j9yh6","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:34:15","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-05 16:34，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-05-1630-gfep1d","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:30:24","subject":"公告本公司董事會通過114年第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-05 16:30，「公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-05-1624-92x690","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:24:33","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-05 16:24，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-05-1619-1boc162","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:19:09","subject":"公告本公司民國114年度第4季個體財務報告","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-05 16:19，「公告本公司民國114年度第4季個體財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1614-rzrc2u","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:14:54","subject":"本公司董事會決議辦理私募發行國內可轉換公司債（包括有擔保或無擔保可轉換公司債）","clause":"第11款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 16:14，「本公司董事會決議辦理私募發行國內可轉換公司債（包括有擔保或無擔保可轉換公司債）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1613-mxqyj5","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:13:47","subject":"本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」之債權人公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 16:13，「本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」之債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-05-1613-6hifxe","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:13:16","subject":"公告本公司民國114年度第4季合併財務報告","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-05 16:13，「公告本公司民國114年度第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1612-qr6lvv","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:12:22","subject":"本公司董事會決議辦理私募發行普通股","clause":"第11款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 16:12，「本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1608-za0iyu","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:08:48","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案","clause":"第16款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 16:08，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1607-1krphe5","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:07:31","subject":"公告本公司董事會通過修訂國內第一次有擔保轉換公司債發行及轉換辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 16:07，「公告本公司董事會通過修訂國內第一次有擔保轉換公司債發行及轉換辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1606-1x4dr6m","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:06:58","subject":"公告本公司董事會通過代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 16:06，「公告本公司董事會通過代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-05-1606-1dd9qx8","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:06:50","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-05 16:06，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1606-1f1swft","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:06:11","subject":"公告本公司取得會計師114年度內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 16:06，「公告本公司取得會計師114年度內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-03-05-1605-5j9yh6","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"16:05:28","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-03-05 16:05，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-05-1602-14lwgbh","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"16:02:11","subject":"本公司114年度財務報告董事會預計召開日期為115年03月13日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-05 16:02，「本公司114年度財務報告董事會預計召開日期為115年03月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1556-1u7pahz","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"15:56:57","subject":"董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 15:56，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1552-5j9yh6","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"15:52:53","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 15:52，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-03-05-1549-11b1948","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"15:49:26","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-03-05 15:49，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-05-1544-z6kweo","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:44:32","subject":"公告本公司民國114年度合併暨個體財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-05 15:44，「公告本公司民國114年度合併暨個體財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-05-1541-we1j9x","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:41:18","subject":"公告本公司開發之動物用骨關節炎長效止痛新藥「撲疼樂Bupanlar」，經農業部防檢署評估，適用動物用新藥檢驗登記優先審查程序。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-05 15:41，「公告本公司開發之動物用骨關節炎長效止痛新藥「撲疼樂Bupanlar」，經農業部防檢署評估，適用動物用新藥檢驗登記優先審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-03-05-1539-15dml9d","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"15:39:47","subject":"公告本公司114年度財務報告提報董事會召開日期","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-03-05 15:39，「公告本公司114年度財務報告提報董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-05-1539-sjl8ul","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:39:17","subject":"公告本公司114年度合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-05 15:39，「公告本公司114年度合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-05-1532-r0v3cd","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-05","time":"15:32:24","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌新藥GNTbm-38，取得紐西蘭發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-05 15:32，「公告華上生醫自主開發新一代表觀免疫調控抗癌新藥GNTbm-38，取得紐西蘭發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-03-05-1525-xg6ked","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:25:41","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月13日","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-03-05 15:25，「公告本公司114年度財務報告董事會預計召開日期為115年3月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-05-1522-1eccy53","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:22:40","subject":"公告本公司法人董事之代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-05 15:22，「公告本公司法人董事之代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-05-1500-1cqrvvt","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"15:00:44","subject":"114年度第四季合併財務報告預計召開日期為115年3月13日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-05 15:00，「114年度第四季合併財務報告預計召開日期為115年3月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-05-1452-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"14:52:06","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」澳洲專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-05 14:52，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-05-1451-1insbm6","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"14:51:24","subject":"本公司因近期股(債)價價格異常，應櫃買中心要求公布相關資訊，以利投資人區別暸解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-05 14:51，「本公司因近期股(債)價價格異常，應櫃買中心要求公布相關資訊，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-03-05-1436-wvk3yp","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-03-05","time":"14:36:39","subject":"公告本公司董事長訂定114年下半年度現金股利除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-03-05 14:36，「公告本公司董事長訂定114年下半年度現金股利除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-03-05-1129-1thr3hr","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-03-05","time":"11:29:28","subject":"公告本公司114年第四季財務報告董事會預計召開日期為115年03月13日","clause":"第31款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-03-05 11:29，「公告本公司114年第四季財務報告董事會預計召開日期為115年03月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}